Answers are grounded in this paper and cite their sources.
Currently, detecting SARS-CoV-2 RNAs is a standard approach for COVID-19 diagnosis. However, there is an urgent need for reliable and rapid serological diagnostic methods to screen SARS-CoV-2-infected people including those who do not have overt symptoms. Most emerging studies described serological tests based on detection of SARS-CoV-2-specific IgM and IgG. 1 , 2 , 3 , 4 Although detection of SARS-CoV-2-specific IgA in serum has been reported in few papers, 5 , 6 analyses of IgA levels in a larger number of COVID-19 patients are still lacking.
No takes yet. Share an insight, caveat, or question.
Ma et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: